Bank Of China Limited - Net Worth and Insider Trading

Bank Of China Limited Net Worth

The estimated net worth of Bank Of China Limited is at least $888 Million dollars as of 2024-09-29. Bank Of China Limited is the 2201 Interest of corporation controlled by you of SciClone Pharmaceuticals (Holdings) Ltd and owns about 47,426,727 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) stock worth over $888 Million. Details can be seen in Bank Of China Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bank Of China Limited has not made any transactions after 2023-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bank Of China Limited

To

Bank Of China Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bank Of China Limited owns 1 companies in total, including SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) .

Click here to see the complete history of Bank Of China Limited’s form 4 insider trades.

Insider Ownership Summary of Bank Of China Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:06600 SciClone Pharmaceuticals (Holdings) Ltd 2023-03-10 2201 Interest of corporation controlled by you

Bank Of China Limited Latest Holdings Summary

Bank Of China Limited currently owns a total of 1 stock. Bank Of China Limited owns 47,426,727 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) as of March 10, 2023, with a value of $888 Million.

Latest Holdings of Bank Of China Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06600 SciClone Pharmaceuticals (Holdings) Ltd 2023-03-10 47,426,727 18.72 887,828,329

Holding Weightings of Bank Of China Limited


Bank Of China Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Bank Of China Limited has made a total of 3 transactions in SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in SciClone Pharmaceuticals (Holdings) Ltd is the sale of 31,193,403 shares on March 10, 2023, which brought Bank Of China Limited around $314 Million.

Insider Trading History of Bank Of China Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bank Of China Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bank Of China Limited Ownership Network

Ownership Network List of Bank Of China Limited

No Data

Ownership Network Relation of Bank Of China Limited

Insider Network Chart

Bank Of China Limited Owned Company Details

What does SciClone Pharmaceuticals (Holdings) Ltd do?

Who are the key executives at SciClone Pharmaceuticals (Holdings) Ltd?

Bank Of China Limited is the 2201 Interest of corporation controlled by you of SciClone Pharmaceuticals (Holdings) Ltd. Other key executives at SciClone Pharmaceuticals (Holdings) Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2101 Beneficial owner Zhao Hong , and Gl Capital Management Gp Limited .

SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) Insider Trades Summary

Over the past 18 months, Bank Of China Limited made no insider transaction in SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600). Other recent insider transactions involving SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) include a net purchase of 354,500 shares made by UBS Group AG , a net sale of 0 shares made by Zhao Hong , and a net sale of 0 shares made by Ascendent Capital Partners Ii Gp Limited .

In summary, during the past 3 months, insiders sold 0 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) were sold and 354,500 shares were bought by its insiders, resulting in a net purchase of 354,500 shares.

SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

SciClone Pharmaceuticals (Holdings) Ltd Insider Transactions

No Available Data

Bank Of China Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Bank Of China Limited. Currently GuruFocus does not have mailing address information for Bank Of China Limited.

Discussions on Bank Of China Limited

No discussions yet.